Elite Pharmaceuticals, Inc. Revenues
Elite Pharmaceuticals, Inc. (ELTP) reported Revenues of $25.38 million for the 12-month period ending 2021-03-31, per its 10-K filed 2021-06-14.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2021-06-14
- Elite Pharmaceuticals, Inc. revenues for the quarter ending 2021-03-31 was $4.40M, a 11.12% decline year-over-year.
- Elite Pharmaceuticals, Inc. revenues for the quarter ending 2020-12-31 was $6.05M, a 19.61% increase year-over-year.
- Elite Pharmaceuticals, Inc. revenues for the quarter ending 2020-09-30 was $7.40M, a 59.65% increase year-over-year.
- Elite Pharmaceuticals, Inc. revenues for the quarter ending 2020-06-30 was $7.54M, a 124.42% increase year-over-year.
- Elite Pharmaceuticals, Inc. revenues for fiscal 2021 was $25.38M, a 41.05% increase from fiscal 2020.
- Elite Pharmaceuticals, Inc. revenues for fiscal 2020 was $17.99M, a 137.76% increase from fiscal 2019.
- Elite Pharmaceuticals, Inc. revenues for fiscal 2019 was $7.57M, a 1.47% increase from fiscal 2018.
- Elite Pharmaceuticals, Inc. revenues for fiscal 2018 was $7.46M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2021-03-31 | $4.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-14 | $10.44M derived: sum of 2 quarters · filed 2021-06-14 | $17.84M derived: sum of 3 quarters · filed 2021-06-14 | $25.38M 10-K · filed 2021-06-14 |
| 2020-12-31 | $6.05M 10-Q · filed 2021-02-16 | $13.45M derived: sum of 2 quarters · filed 2021-02-16 | $20.99M 10-Q · filed 2021-02-16 | $25.93M derived: sum of 4 quarters · filed 2021-06-14 |
| 2020-09-30 | $7.40M 10-Q · filed 2020-11-16 | $14.94M 10-Q · filed 2020-11-16 | $19.88M derived: sum of 3 quarters · filed 2021-06-14 | $24.94M derived: sum of 4 quarters · filed 2021-06-14 |
| 2020-06-30 | $7.54M 10-Q · filed 2020-08-14 | $12.48M derived: sum of 2 quarters · filed 2021-06-14 | $17.54M derived: sum of 3 quarters · filed 2021-06-14 | $22.17M derived: sum of 4 quarters · filed 2021-06-14 |
| 2020-03-31 | $4.95M derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-14 | $10.00M derived: sum of 2 quarters · filed 2021-06-14 | $14.64M derived: sum of 3 quarters · filed 2021-06-14 | $17.99M 10-K · filed 2021-06-14 |
| 2019-12-31 | $5.06M 10-Q · filed 2021-02-16 | $9.69M derived: sum of 2 quarters · filed 2021-02-16 | $13.05M 10-Q · filed 2021-02-16 | $14.39M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-09-30 | $4.63M 10-Q · filed 2020-11-16 | $7.99M 10-Q · filed 2020-11-16 | $9.34M derived: sum of 3 quarters · filed 2020-11-16 | $12.03M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $3.36M 10-Q · filed 2020-08-14 | $4.70M derived: sum of 2 quarters · filed 2020-08-14 | $7.40M derived: sum of 3 quarters · filed 2020-08-14 | $8.76M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-29 | $4.04M derived: sum of 2 quarters · filed 2020-06-29 | $5.40M derived: sum of 3 quarters · filed 2020-06-29 | $7.57M 10-K · filed 2020-06-29 |
| 2018-12-31 | $2.69M 10-Q · filed 2020-02-10 | $4.06M derived: sum of 2 quarters · filed 2020-02-10 | $6.22M 10-Q · filed 2020-02-10 | $7.82M derived: sum of 4 quarters · filed 2020-02-10 |
| 2018-09-30 | $1.36M 10-Q · filed 2019-11-12 | $3.53M 10-Q · filed 2019-11-12 | $5.13M derived: sum of 3 quarters · filed 2019-11-12 | $7.66M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $2.17M 10-Q · filed 2019-08-09 | $3.76M derived: sum of 2 quarters · filed 2019-08-09 | $6.30M derived: sum of 3 quarters · filed 2019-08-09 | $7.92M derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-21 | $4.13M derived: sum of 2 quarters · filed 2019-06-21 | $5.76M derived: sum of 3 quarters · filed 2019-06-21 | $7.46M 10-K · filed 2019-06-21 |
| 2017-12-31 | $2.54M 10-Q · filed 2019-02-11 | $4.16M derived: sum of 2 quarters · filed 2019-02-11 | $5.86M 10-Q · filed 2019-02-11 | |
| 2017-09-30 | $1.62M 10-Q · filed 2018-11-09 | $3.33M 10-Q · filed 2018-11-09 | ||
| 2017-06-30 | $1.70M 10-Q · filed 2018-08-09 |